February 19, 1999

7 a.m.-8:30 a.m.
Industry-Supported Symposia
IS19. Part II: Anxiety and Depression: Cause or Effect? Supported by Wyeth-Ayerst Laboratories
A. Impact of Depression on the Course of Anxiety Disorders Jane L. Eisen, M.D.
B. Anxious Depression: Clinical Characteristics and Treatment Options James C. Ballenger, M.D.

IS20. Part II: New Clinical Advances in Managing Anxiety and Depressive Disorders Supported by Bristol-Myers Squibb
A. Emerging Clinical Strategies for Comprehensive Treatment of PTSD Thomas A. Mellman, M.D.
B. New Advances in the Treatment of Panic Disorder Justine M. Kent, M.D.

IS21. Part II: Beyond Efficacy in Psychosis: Patient Satisfaction, Compliance, and Outcomes Supported by Zeneca Pharmaceuticals
A. Hyperprolactinemia and Sexual Dysfunction: Relationship to Patient Satisfaction and Adherence Lili C. Kopala, M.D.
B. Involving the Caregiver to Optimize Outcomes in Psychosis Laurie M. Flynn

IS22. Part II: Strategies and Tactics to Manage Depressed Patients Supported by Organon Inc.
A. Are There Faster and Slower Psychotherapy Responders? John C. Markowitz, M.D.
B. Early Antidepressant Response as a Predictor Lorrin M. Koran, M.D.

IS23. Part II: Controversies and Treatment Strategies in Bipolar Disorders Supported by Abbott Laboratories
A. Compliance and Safety: Issues Integral to Successful Bipolar Therapy Carlos A. Zarate Jr., M.D.
B. What’s New in Pharmacoeconomic Treatment Outcomes in Bipolar Disorder Lisa B. Dixon, M.D.

7:30 a.m.-6 p.m.
Registration/Course Enrollment Open

8 a.m.-Noon
CME Courses 51-58

9 a.m.-10:30 a.m.
Clinical Case Conference 2. Roslyn Seligman, M.D., on Manic-Depressive Illness: Over- , Under- , or Misdiagnosis? (Open to APA members only.)

Discussion Groups
4. Gabriela Cora-Locatelli, M.D., on Surviving the Boards (Open to residents only.)

Lectures
L8. Psychiatry’s Shifting Foundation: Research Up, Reimbursement Down, Managed Care Challenged Herbert Pardes, M.D., Distinguished Psychiatrist Lecture Series
L9. How Neuroscience Continues to Change Psychiatry Steven E. Hyman, M.D., Distinguished Psychiatrist Lecture Series Collaborative Session With the National Institute of Mental Health

Master Educator Clinical Consultations
5. Judith H. Gold, M.D., on The Impact of the Therapist’s Life Events on the Conduct of Psychotherapy (Open to APA members only.)
6. Robert Cancro, M.D., on Office Management of Schizophrenic Disorders (Open to APA members only.)
7. Max Fink, M.D., and C. Edward Coffey, M.D. on Contemporary Practice of ECT (Open to APA members only.)

New Research Oral/Slide Sessions

Component Workshops
CW19. Legal Update: Managed Care, Privacy, and Sex Offenders APA Council on Psychiatry and Law and APA Commission on Judicial Action Chairperson: Renee L. Binder, M.D.
CW20. Making Order Out of Chaos: Residents and Institutions APA Committee of Residents and Fellows Chairperson: Derek G. Puddester, M.D.
CW21. Task Force on Quality Indicators: Status Report APA Task Force on Quality Indicators Co-Chairpersons: John M. Oldham, M.D., and Deborah A. Zarin, M.D.
CW22. First Impressions: Assumptions Exposed APA/Center for Mental Health Services Minority Fellowship and APA/Zeneca Minority Fellowship Co-Chairpersons: Petros Levounis, M.D., and Deborah Liggan, M.D.
CW23. The Healing Ways of the Anishinaabe Ojibwe People APA Committee of American Indian, Alaska Native, and Native Hawaiian Psychiatrists Co-Chairpersons: Robert C. Palmer, M.D., and Blackwolf Jones, M.S.
CW24. Medications in Addiction Therapy APA Council on Addiction Psychiatry and American Academy of Addiction Psychiatry Chairperson: Sheldon I. Miller, M.D.
CW25. Lost in Diversity Mainstream APA Committee of Black Psychiatrists Co-Chairpersons: Michelle O. Clark, M.D., and Sheryl D. Jones, M.D.
CW26. Substance Abuse, Violence, and the Hispanic Family APA Committee of Hispanic Psychiatrists Chairperson: Silvia W. Olarte, M.D.
CW27. Treating Homosexuals: Dos and Don’ts APA New York County District Branch’s Committee on Gay and Lesbian Issues Co-Chairpersons: Kenneth B. Ashley, M.D., and John A. Gosling, M.D.

Issue Workshops
IW16. Children of Psychiatrist Parents: Part II Co-Chairpersons: Leah J. Dickstein, M.D., and Michelle Riba, M.D.
IW17. Understanding the Dynamics of Abusive Relationships Chairperson: Gary J. Maier, M.D.
IW18. Gay and Lesbian Substance Abuse Treatment: Cultural Competency Training Chairperson: Saul M. Levin, M.D.
IW19. Clinical Responses to Managed Health Care Chairperson: Harold J. Bursztajn, M.D.
IW20. The International War Crimes Tribunal: Psychiatry’s Role Chairperson: Landy F. Sparr, M.D.
IW21. Poems on Psychiatry Chairperson: Charles R. Joy, M.D.
IW22. Clinical Skills Assessment and Psychiatry Training Chairperson: Nyapati R. Rao, M.D.
IW23. Case Formulation: Three Alternative Viewpoints Chairperson: Marcia J. Kaplan, M.D.
IW24. Leadership in Organizational Transitions Chairperson: Stewart Gabel, M.D.

9 a.m.-11 a.m.
Media Sessions
Session 11. Multicultural Women’s Perspectives on Diversity
15. The Way Home

Session 12. Using Computers for Medical Records and Treatment Planning
16. Computerizing Medical Records for a Large Outpatient Division
17. Using an Access-Based Relational Database
18. Computer-Assisted Assessment Psychotherapy Education and Research (CAPER) Treatment Planner

Session 13. Film and Healing: Maya, Compassion and I - Thou in Chaplin’s City Lights
19. City Lights

Research Advances in Medicine
Research Advances in Herbal and Alternative Medicine: Biological and Clinical Effects Philip R. Muskin, M.D.

9 a.m.-Noon
AIDS Education Program
Part I: Clinical and Neuropsychiatric Dimensions of HIV Disease APA Commission on AIDS
A. AIDS and HIV Disease: A Medical Update To Be Announced
B. Neuropsychiatric Manifestations and Their Treatments: A Review Mark H. Halman, M.D, and Karl Goodkin, M.D.

Continuous Clinical Case Conference, Part II Arthur J. Barsky III, M.D., on Treating Patients With Medically Unexplained Symptoms (Open to APA members only.)

9 a.m.-12:30 p.m.
Review of Psychiatry, Part II: Male Psychosexuality Co-Chairpersons: Richard C. Friedman, M.D., and Jennifer I. Downey, M.D.
6. Male Sexual Fantasy and Behavior: Selected Clinical Issues Richard C. Friedman, M.D.
7. Male Heterosexuality Stephen B. Levine, M.D.
8. The Evaluation and Treatment of Erectile Dysfunction Stanley E. Althof, Ph.D.
9. Casualities of Recovered Memory Therapy: The Impact of False Allegations of Incest on Accused Fathers Harold I. Lief, M.D.
10. Fatherhood As a Transformation of the Self: Toward a New Psychology of Boys and Men William S. Pollack, M.D.

9 a.m.-4 p.m.
CME Courses 59-65

10 a.m.-6 p.m.
Exhibits Open
Publishers’ Bookfair Open
APA Resource Center Open

11 a.m.-12:30 p.m.
Discussion Group
5. David A. Goldberg, M.D., on Evidence-Based Medicine and Current Psychiatric Practice

Lectures
L10. Childhood Maltreatment and Adverse Outcomes: A Prospective Developmental Approach Frank W. Putnam Jr., M.D., Frontiers of Science Lecture Series
L11. Early Intervention Strategies in Different Phases of Schizophrenia: How Effective? Marvin I. Herz, M.D., Distinguished Psychiatrist Lecture Series

Master Educator Clinical Consultations
8. Clarice J. Kestenbaum, M.D., on Psychotherapy of Multimodal Bipolar Adolescents (Open to APA members only.)
9. David V. Sheehan, M.D., on Anxiety and Mood Disorders (Open to APA members only.)

Medical Update
2. Gary L. Simon, M.D., on Advances in the Treatment of HIV Infection

Research Consultation With
1. Fawzy I. Fawzy, M.D., on Psychosocial Interventions as an Integral Part of Comprehensive Cancer Care

Scientific and Clinical Report Sessions
Session 9. Cultural and Race Issues in Mental Illness
26. Management of Major Depression in Hispanic Patients in the Primary Care Setting David Mischoulon, M.D.
27. Effect of Race on Residential Treatment Outcomes Kathleen M. Stack, M.D.
28. Eating Disorders: A True Western Culture-Bound Syndrome? Katarzyna Bisaga, M.D.

Session 10. Current Issues in Forensic Psychiatry
29. Incompetent, Unrestorable Patients: A New Approach Howard H. Sokolov, M.D.
30. Effect of Outpatient Commitment on Treatment Compliance in Schizophrenia Barbara M. Rohland, M.D.
31. Schizophrenic Violence: Relationship to Symptoms Menahem Krakowski, M.D.

Session 11. Prognostic Factors in the Treatment of Schizophrenia
32. Premorbid Associality and Neuropsychological Status Marshall L. Silverstein, Ph.D.
33. Negative Symptoms and Functioning in Schizophrenia Ellen S. Herbener, Ph.D.
34. Do Schizoaffective Patients Have a Chronic Course? Martin Harrow, Ph.D.

Session 12. Depression and the Life Cycle in Women
35. Past Depression and Middle-Aged Women’s Health Joyce T. Bromberger, Ph.D.
36. Symptom Expression in Postpartum Mood Disturbance Ruta M. Nonacs, M.D.
37. The Use of Nortriptyline for Prevention of Postpartum Depression in a High-Risk Group of Women Kathleen S. Peindl, Ph.D.

Session 13. Burning Issues in Psychiatric Education
38. Effects of Managed Care on Psychiatric Education Amy C. Brodkey, M.D.
39. Impact of Patient Suicide on Psychiatric Trainees Ronald Ruskin, M.D.
40. A Model Psychopharmacology Curriculum Ira D. Glick, M.D.

Session 14. Diagnosis and Treatment of Menstrual Cycle Disorders
41. Variability of Depressive Symptoms During the Menstrual Cycle Hadine Joffe, M.D.
42. PMS and Mental Health During Menopause Claudio de Novaes Soares, M.D.
43. Fluoxetine’s Efficacy in Improving Physical Symptoms Associated With PDD: Results From a Multisite, Randomized, Placebo-Controlled Trial Meir Steiner, M.D.

Session 15. Comorbidity of Anxiety and Depression
44. Comparison of Social Functioning in Patients With Anxious Depression or MDD Shamsah B. Sonawalla, M.D.
45. Anxiety Disorders in Major Depression Maurizio Fava, M.D.
46. Depression and Anxiety Comorbidity Using the Prime-MD Mary Kay Smith, M.D.

Session 16. HIV and Psychoimmunology
47. The Option of Euthanasia for HIV Disease in Europe Panayiotis I. Vyras, M.D.
48. Immunological Status Versus Depression as Predictors of Quality of Life in HIV-Infected Individuals Jose R. Maldonado, M.D.
49. Diurnal Cortisol and Early Cancer Mortality David Spiegel, M.D.

Component Workshops
CW28. Recruitment and Retention: It’s Everyone’s Job! APA Membership Committee Chairperson: Bernard A. Katz, M.D.
CW29. Cultural/Ethnic Identity: Impact on Self-Esteem and Success APA Committee of International Medical Graduates, APA Committee of Asian-American Psychiatrists, and APA Committee of Hispanic Psychiatrists Co-Chairpersons: Gopalakrishna K. Upadhya, M.D., and Edmond H. Pi, M.D.
CW30. Media Skills for Members-in-Training and Early Career Psychiatrists Co-Chairpersons: Nada L. Stotland, M.D., and Donna T. Chen, M.D.
CW31. History of Empowerment by the Mentally Ill APA Committee on History and Library Chairperson: Janet E. Ordway, M.D.
CW32. Homophobia Hurts Families: How Parents, Families, and Friends of Lesbians and Gays Can Help APA Washington Psychiatric Society’s Gay and Lesbian Committee Chairperson: Daniel W. Hicks, M.D.
CW33. Health Awareness Education for Medical Students APA Committee on Medical Student Education Chairperson: Michael J. Vergare, M.D.
CW34. Managed Care Funding for Psychiatric Consults APA Committee on Standards and Survey Procedures and APA Committee on Consultation-Liaison Psychiatry and Primary Care Education Co-Chairpersons: Carol L. Alter, M.D., and Francisco Fernandez, M.D.

Issue Workshops
IW25. International Views on Practice Guidelines Chairperson: Timothy B. Sullivan, M.D.
IW26. Psychiatric Training of International Medical Graduates: Residents’ Perspectives Co-Chairpersons: Pedro Ruiz, M.D., and Fuad J. Antuna, M.D.
IW27. Psychiatry and Religion: Conceptual Considerations Chairperson: Avak A. Howsepian, M.D.
IW28. Spiritual and Ethical Issues in End-of-Life Care Co-Chairpersons: Christina M. Puchalski, M.D., and Ellen Fox, M.D.
IW29. How to Write and Publish in Psychiatry Chairperson: Carol C. Nadelson, M.D.
IW30. Sexual Harassment in School: Context and Curricula Chairperson: Patricia R. Recupero, M.D.
IW31. Family Values: Lesbian and Gay Family Constellations Chairperson: Ellen Haller, M.D.
IW32. Perils and Problems in Sexual Harassment Cases Chairperson: Rita R. Newman, M.D.
IW33. Prescribing Controlled Substances: Risk Management Chairperson: Lance P. Longo, M.D.

Media Sessions
Session 14. The Trauma of Genocide: Social and Personal Healing
20. Crimes Against Humanity: Justice Pursued
21. Secrets of S-21: Legacy of a Cambodian Prison
22. When Helping Hurts: Sustaining Trauma Workers

Session 15. Beyond Stereotypes: Exploring American Indian Cultural Identity
23. Smoke Signals

Noon-1:30 p.m.
Forums
3. Safe Schools and Dangerous Kids: Pathways to Violence Chairperson: James Garbarino, Ph.D.
4. Can We Talk? Psychotherapy by Psychiatrists in Managed Care APA Commission on Psychotherapy by Psychiatrists Chairperson: Norman A. Clemens, M.D.

Noon-2 p.m.
New Research Poster Session

1 p.m.-5 p.m.
CME Courses 66-74

2 p.m.-3:30 p.m.
Lectures
L12. Doctor, Where Are You From? The International Medical Graduate in the United States Silvia W. Olarte, M.D., APA’s George Tarjan Award Lecture
L13. Women in Medical Leadership: How Far, Baby? Carolyn B. Robinowitz, M.D., APA’s Administrative Psychiatry Award Lecture

2 p.m.-5 p.m.
Media Sessions
Session 16. Coping With Emotional Aspects of Medical Illness and Physician Suicide
24. Whose Death Is It Anyway?
25. When All Is Said and Done
26. When Physicians Commit Suicide: Reflections of Those Left Behind

Session 17. Up-to-Date Psychiatry Through the Internet
27. Geriatrics: Women’s and Men’s Health
28. Psychopharmacology Tips
29. Forensic Psychiatry
30. The Treatment of Depression in Long-Term Care: Interactive CD-ROM Training
31. A World Wide Web Survey of Physician Knowledge of Alzheimer’s Disease

Session 18. A French Perspective on BPD: Betty Blue
32. Betty Blue

Presidential Symposium
State Medicaid Programs: Access and Quality for Mental Health Care Chairperson: Rodrigo A. Muñoz, M.D. Participant: Mary Jane England, M.D.

Symposia
S19. Medication Controversies in Bipolar Disorder
A. Mood Stabilizing Medication Paul E. Keck Jr., M.D.
B. The Role of Antipsychotics in Bipolar Disorder Philip G. Janicak, M.D.
C. Bipolar Depression Gary S. Sachs, M.D.
D. Novel Treatment Strategies for Refractory Bipolar Disorder Andrew L. Stoll, M.D.

S20. The Ethics of Schizophrenia Research
A. Overview of the Controversy Paul S. Appelbaum, M.D.
B. An Overview of the National Bioethics Advisory Commission’s Report and Recommendations James F. Childress, Ph.D.
C. Ethical Issues in Clinical Research: An Investigator’s Perspective Jeffrey A. Lieberman, M.D.
D. Evolving Procedures to Address Research Ethics William T. Carpenter Jr., M.D.
E. Clinical Trials of Treatments for Schizophrenia Robert J. Levine, M.D.

S21. Group Therapy for Persons Living With HIV/AIDS
A. Enhancing Coping Skills in Group Psychotherapy for People With HIV/AIDS Jeffrey A. Kelly, Ph.D.
B. Interventions for Positive Youth: Are Groups the Right Modality? Mary J. Rotheram-Borus, Ph.D.
C. Bereavement Groups and Distress After Subsequent Loss Karl Goodkin, M.D.
D. Supportive-Expressive Group Therapy for HIV/AIDS Cheryl Koopman, Ph.D.

S22. Treatment of Suicidal Behavior in Persons With Personality Disorders
A. Suicidal Behavior in Persons With Personality Disorders Barbara Stanley, Ph.D.
B. Psychopharmacology of Suicidal Behavior in Persons With Personality Disorders Larry J. Siever, M.D.
C. Psychotherapy of Suicidal Patients With Personality Disorders Marsha M. Linehan, Ph.D.
D. Clinical Management of the Suicidal Personality-Disordered Patient Rebecca A. Dulit, M.D.

S23. Substance Abuse and Comorbidity
A. Treatment of PTSD and Substance Use Disorders Kathleen T. Brady, M.D.
B. Evaluation of Depression in Substance Abuse David M. McDowell, M.D.
C. Diagnosis and Treatment: Substance Abusers With ADHD Frances R. Levin, M.D.
D. Dual Diagnosis: Schizophrenia and Substance Abuse Douglas M. Ziedonis, M.D.
E. Axis II in Drug Abusers: Relation to Axis I Bruce J. Rounsaville, M.D.

S24. Biology of Eating Disorders: Clinical Implications
A. Perturbations in Metabolic Rate in Persons With Anorexia Nervosa Laurel Mayer, M.D.
B. Metabolic Signals and Body Weight in Persons With Bulimia Nervosa David C. Jimerson, M.D.
C. Eating Behavior in Patients With Eating Disorders Michael J. Devlin, M.D.
D. Gastric Function in Persons With Bulimia Nervosa Ellen Zimmerli, Ph.D.
E. Orbital Frontal Serotonin Changes in Recovered Bulimics Walter H. Kaye, M.D.

S25. Demonstrating Psychiatry’s Impact on Medical Care and Cost
A. Proving Medical Psychiatry Is Worth Its Cost Jonathan F. Borus, M.D.
B. Cost-Offset From Psychiatric Interventions in Medicine James J. Strain, M.D.
C. Predictors of Delirium Following Abdominal Aortic Aneurysm Sarah L. Minden, M.D.
D. Mental Disorders in Primary Care and Medical Utilization Lisa A. Carbone, M.D.
E. Cost-Offset Versus Cost-Effectiveness: Which Paradigm for Psychiatric Treatment Trials? Wayne J. Katon, M.D.

S26. New Treatment Targets in Schizophrenia
A. Pharmacological Treatment of Negative Symptoms Robert W. Buchanan, M.D.
B. Cognitive Deficits as Treatment Targets James M. Gold, Ph.D.
C. Depression and Suicidality as Targets for Intervention in Schizophrenia Wayne S. Fenton, M.D.
D. Approaches to Substance Abuse in Schizophrenia Fred C. Osher, M.D.
E. The Need and Challenge of Providing Services to Families Lisa B. Dixon, M.D.

S27. Psychiatric Workforce: Issues and Challenges
A. Workforce Assumptions: International Perspective James H. Scully Jr., M.D.
B. Definition of a Psychiatrist for the New Millennium Allan Tasman, M.D.
C. Estimating Workforce Requirements Based on Patients’ Needs Larry R. Faulkner, M.D.
D. Physician Maldistribution and the Role of International Medical Graduates Nyapati R. Rao, M.D.
E. Manpower Issues: Canada’s Experience Nady El-Guebaly, M.D.

S28. Psychiatry in the Second Decade of the HIV Pandemic
A. Mechanisms and Impact of HIV Neurocognitive Complications Igor Grant, M.D.
B. Mood Disorders in HIV Infection Constantine G. Lyketsos, M.D.
C. Psychiatric Aspects of Substance Use Disorders and HIV Steven L. Batki, M.D.
D. HIV/AIDS and the Severely Mentally Ill Alan Berkman, M.D.
E. Antiretroviral Therapy of HIV Cognitive Disorders J. Hampton Atkinson Jr., M.D.
F. Psychiatric Vectors of Infectious Disease Glenn J. Treisman, M.D.

S29. Depression Subtypes in General Hospitals
A. Most Frequent Depressive Disorders in a General Hospital Rodolfo D. Fahrer, M.D.
B. The Consultation-Liaison Psychiatrist and Depression in the General Hospital Don R. Lipsitt, M.D.
C. Relapse and Recurrency After the First Depressive Episode Gerardo Heinze, M.D.
D. First-Episode Affective Disorders With Psychotic Features: Outcome Mauricio F. Tohen, M.D.
E. Comorbidity Factors in Depressive Illness Pedro Ruiz, M.D.

S30. The Neuroscience of Severe Mental Disorders Collaborative Session With the National Institute of Mental Health
A. Early Developmental Events in the Regional Identity of the Cerebral Cortex Pat Levitt, Ph.D.
B. Depression: Advances in Postmortem Histopathology Grazyna Rajkowska, Ph.D.
C. Functions of the Amygdala in Attention and Cognition Michela Gallagher, Ph.D.
D. Emotion, Memory, and the Brain Joseph E. LeDoux, Ph.D.

S31. Drug-Induced Movement Disorders in Older Adults
A. An Overview of Common Drug-Induced Movement Disorders Sanjay Gupta, M.D.
B. Tardive Dyskinesia: Typical Versus Atypical Antipsychotics Dilip V. Jeste, M.D.
C. Prospective Study of Tardive Dyskinesia in the Elderly John M. Kane, M.D.
D. Dyskinesia and Ethnicity in Elderly Schizophrenia Patients William B. Lawson, M.D.
E. Neuroleptic-Induced Parkinsonism in Alzheimer’s Disease Robert A. Sweet, M.D.

S32. Violence, Social Change, and Women’s Health World Psychiatric Association’s Task Force on Violence
A. Social and Clinical Aspects of Battered Women Syndrome Tatyana Dmitrieva
B. Broken Hearts: Ischemic Heart Disease, Depression, and Gender Donna E. Stewart, M.D.
C. Violence Against Women in Egypt: A Reading in the Egyptian Context Aida Self El Dawla, M.D.
D. Global Violence Against Women and Children Marianne C. Kastrup, M.D.
E. Violence: A Global Public Health, Behavioral Health, and Primary Care Challenge Eliot Sorel, M.D.

S33. Understanding School Violence
A. Trends in School Violence Kathleen M. Fisher, Ph.D.
B. A Typology of School Violence Lois T. Flaherty, M.D.
C. Biological and Cultural Causes of Violence Paul A. Kettl, M.D.
D. Violence Prevention in Chicago Public Schools Carl C. Bell, M.D.
E. Problems of and Solutions for School Violence Paul Jay Fink, M.D.

S34. Cultural and Language Considerations in Diagnosis
A. Validation of a Structured Interview in European Settings Yves Lecrubier, M.D.
B. Russian Language Assessment of Mental Illness Alexander Bystritsky, M.D.
C. The Psychiatric Assessment of Arab Patients Ossama T. Osman, M.D.
D. Psychiatric Diagnosis and Structured Interviews in Hebrew Raphael E. Barda, M.D.
E. Diagnostic Challenges in Southern African Languages Kerunne Ketlogetswe

S35. Pharmacology Intervention in Women at Risk for Infanticide
A. Prevention and Treatment of Postpartum Mood Disorders Katherine L. Wisner, M.D.
B. Maternal Infanticide Phillip J. Resnick, M.D.
C. Infanticide: An Epidemiological Perspective Paula M. Bortnichak, M.D.
D. Mothers Who Kill: Neonaticide and the Law Michelle Oberman, J.D.
E. Neonaticide in America: A Systematic Investigation Margaret G. Spinelli, M.D.

S36. Working in a Flawed System: The Ethical Dilemmas
A. The Ethics of Working in a Flawed Health Care System Stephen A. Green, M.D.
B. Ethical and Clinical Aspects of Psychotherapy Services Within a National Health Service Framework Jeremy Holmes, M.D.
C. Rationing, Responsibility, and the Rights of the Child George Halasz, M.B.
D. Psychiatrists as Advocates: Do Ethics Codes Help? Sydney Bloch, M.D.

S37. Resource and Care Management Systems: The Level of Care Utilization System for Psychiatric and Addiction Services, a Child and Adolescent Version American Association of Community Psychiatrists
A. The Level of Care Utilization System for Psychiatric and Addiction Services Development: Historical Background and Structural Principles Wesley E. Sowers, M.D.
B. Implementing the Level of Care Utilization System for Psychiatric and Addiction Services: Opportunities and Barriers Kenneth S. Thompson, M.D.
C. The Child and Adolescent Level of Care Utilization System for Psychiatric and Addiction Services: Developing a Child and Adolescent Version Andres J. Pumariega, M.D.
D. The Level of Care Utilization System by Hand or Personal Computer: A Reliability and Validity Study Charles J. George, M.S.

2 p.m.-5:30 p.m.
Review of Psychiatry, Part III: Countertransference in Psychiatric Treatment Chairperson: Glen O. Gabbard, M.D.
11. Overview of Countertransference: Theory and Technique Glen O. Gabbard, M.D.
12. Countertransference in General Psychiatry Marcia K. Goin, M.D.
13. Countertransference in the Treatment of the Suicidal Borderline Patient John T. Maltsberger, M.D.
14. Countertransference Issues With Antisocial Personality Disorders John R. Lion, M.D.
15. Countertransference and Assisted Suicide Francis T. Varghese, M.B.

3 p.m.-5 p.m.
New Research Poster Session

7 p.m.-10 p.m.
Industry-Supported Symposia
IS24. Alzheimer’s Disease: Translating Clinical Trials Into Clinical Care Supported by Bayer Corporation, Pharmaceutical Division
A. Assessment Tools for Global Function P. Murali Doraiswamy, M.D.
B. Scales Used to Assess Cognition John C. Morris, M.D.
C. Activities of Daily Living: A Key Parameter in Alzheimer’s Disease Linda Teri, Ph.D.
D. Assessment of Neuropsychiatric Disorders Jeffrey L. Cummings, M.D.
E. Assessment of Disease Progression Mary Sano, Ph.D.

IS25. What Makes an Antipsychotic Atypical? Supported by Watson Laboratories Inc.
A. Pharmacological Mechanism of Atypical Antipsychotics Stephen M. Stahl, M.D.
B. Serotonin/Dopamine Antagonism and Atypicality: In Vivo Evidence Using PET Gary J. Remington, M.D.
C. Management of Agitation and Aggression: New Pharmacologic Approaches Peter F. Buckley, M.D.
D. Is There Clinical Evidence for Atypical Effects of Loxapine? William M. Glazer, M.D.
E. Use of Intramuscular Antipsychotics in Acute-Care Settings Larry Ereshefsky, Pharm.D.

IS26. Unmasking Depression and Comorbid Conditions: Clinical Challenges, Solutions, and Unanswered Questions Supported by U.S. Pharmaceuticals, Pfizer Inc.
A. Understanding Depression is a Risk Factor in Vascular Disease K. Ranga R. Krishnan, M.D.
B. Mood Disturbance in Alzheimer’s Disease and Other Neurological Illnesses Pierre N. Tariot, M.D.
C. Management of Depression During Pregnancy and Postpartum Lori L. Altshuler, M.D.
D. Addictons: Smoking, Alcohol, and Cocaine Abuse Barbara J. Mason, Ph.D.

IS27. Gender Issues in Diagnosis and Response to Treatment Supported by Glaxo Wellcome Inc.
A. Gender Issues in Diagnosis and Response to Treatment Teresa A. Pigott, M.D.
B. Gender Issues in the Assessment and Treatment of Depression Susan G. Kornstein, M.D.
C. Treatment of Women With BPD Ellen Leibenluft, M.D.
D. Incidence and Treatment of Migraine in Women Anita L.H. Clayton, M.D.
E. Sexual Disorders in Women: Diagnosis and Treatment Thomas N. Wise, M.D.

IS28. Clinical Applications of New Dementia Research Supported by Novartis Pharmaceuticals Corporation
A. Early Detection and Prevention of Dementia Gary W. Small, M.D.
B. Translating Treatment Data to the Real World Lon S. Schneider, M.D.
C. Neuroimaging Techniques and Applications Steven G. Potkin, M.D.
D. Recent Findings in Behavioral Intervention Jiska Cohen-Mansfield, Ph.D.
E. Management of Comorbid Conditions George T. Grossberg, M.D.

IS29. Managing Depression Across the Life Supported by Forest Laboratories Inc.
A. Depression in Children and Adolescents Graham J. Emslie, M.D.
B. Course and Treatment of Mood Disorders During Pregnancy and the Postpartum Period Zachary N. Stowe, M.D.
C. Depression in the Perimenopausal Woman Peter J. Schmidt, M.D.
D. Long-Term Management of Recurrent Adult Depression Jerrold F. Rosenbaum, M.D.
E. Late-Life Depression: Biologic Vulnerability, Phenomenology, and Course Barnett S. Meyers, M.D.

Media Sessions
Session 19. AIDS: Multicultural Perspectives
33. Odo Ya! Life With AIDS
34. Rainmakers Thailand
35. Women and HIV: Four Stories

Session 20. Exploration of Warfare and Its Consequences
36. Regeneration

Symposia
S38. The Biology of Trauma
A. Studies of Somatization in the Wake of Disaster Carol S. North, M.D.
B. Severity of Trauma Among Refugee Psychiatric Patients: Demographic and Clinical Correlates Joseph J. Westermeyer, M.D.
C. Sleep in PTSD: Findings From Chronic, Recent, and Acute Stages Thomas A. Mellman, M.D.
D. Physiological and Subjective Assessment of Families Bereaved After the Oklahoma City Bombing Phebe M. Tucker, M.D.
E. The Neuroarcheology of Child Maltreatment: Evidence for Altered Neurodevelopment Following Traumatic Abuse Bruce D. Perry, M.D.

S39. New Views on Play in Adults
A. Play in the Lives of Retirees: A 60-Year Study George E. Vaillant, M.D.
B. Emily Dickinson: Play Becomes Poetry John F. McDermott Jr., M.D.
C. Risk-Taking as a Dangerous or Healthy Mechanism Lynn E. Ponton, M.D.
D. Beyond Love and Work: Why Adults Need to Play Lenore C. Terr, M.D.

S40. Understanding and Treating Pathological Gambling
A. Pathological Gambling: Major Public Health Concern Marvin A. Steinberg, Ph.D.
B. Assessing Pathological Gambling Ken C. Winters, Ph.D.
C. Multimodal Behavior Therapy for Pathological Gamblers Iver E. Hand, M.D.
D. Psychopharmacology of Pathological Gambling Marc N. Potenza, M.D.
E. Neurobiology of Pathological Gambling Eric Hollander, M.D.

S41. French and American Psychiatry: Vive La Difference!
A. Suburb’s Psychosis Thierry Tremine, M.D.
B. American Indians in Urban Areas: Dealing With Cultural Differences James W. Thompson, M.D.
C. The Protection of the Well-Being (Rights) of the Mentally Ill Eric Marcel
D. The Protection of the Rights of the Mentally Ill in America Carl P. Malmquist, M.D.
E. What Place for Henri Ey (1900-1977) in a Picture of French Psychiatry in 1998? Suzanne Parizot, M.D.
F. Adolf Meyer and 20th Century Psychiatry Paul R. McHugh, M.D.

S42. Arab Cultural Perspectives on the Assessment and Treatment of Anxiety Disorders
A. Anxiety Disorders and Transcultural Factors in Diagnosis and Treatment Ossama T. Osman, M.D.
B. The Cultural Context of Anxiety Disorders in Egypt Adel Sadek, M.D.
C. The Study of Panic Disorder in Egypt Afaf H. Khalil, M.D.
D. Comorbidity of Social Phobia Among Saudi Patients Ibrahim Al-Khodair, M.D.
E. The Islamic Legal Pespective on Mental Disorder and Impediments to Competency Abdulrazzak M. Alhamad, M.D.

S43. Psychotherapy Training: Is It Relevant Today?
A. Education and Training in Psychodynamics Jerald Kay, M.D.
B. The Role of Psychoanalysis in the Development of the Psychiatrist Norman A. Clemens, M.D.
C. Teaching and Supervising Psychotherapy: Current Issues Judith H. Gold, M.D.
D. Ethical, Gender, and Cultural Issues in Psychotherapy Training Carol C. Nadelson, M.D.
E. Integration of Psychotherapy and Biological Treatments Glen O. Gabbard, M.D.

S44. Prescribing Psychotropics for Diverse Populations APA Council on National Affairs
A. Clinical and Pharmacologic Considerations When Prescribing Psychotropics for Culturally Diverse Populations Sheldon H. Preskorn, M.D.
B. Issues in Ethnic Responses to Psychotropic Medication William B. Lawson, M.D.
C. Psychotropics and Women Freda C. Lewis-Hall, M.D.
D. Ethnicity and Psychotropic Drug Responses Keh-Ming Lin, M.D.
E. Overcoming Psychotropic Drug Non-Compliance: A Cultural Perspective Albert C. Gaw, M.D.